Can an online expressive writing program support people with inflammatory bowel disease? A feasibility randomised controlled trial.
COVID-19
Distress
Expressive writing
Inflammatory bowel disease
SARS-CoV-2
Journal
Complementary therapies in clinical practice
ISSN: 1873-6947
Titre abrégé: Complement Ther Clin Pract
Pays: England
ID NLM: 101225531
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
21
02
2022
revised:
17
05
2022
accepted:
01
06
2022
pubmed:
19
6
2022
medline:
7
7
2022
entrez:
18
6
2022
Statut:
ppublish
Résumé
We explored feasibility, acceptability and preliminary efficacy of an online writing intervention (WriteforIBD) against an active control condition for distress in people with inflammatory bowel disease (IBD) at the time of the COVID-19 pandemic. A feasibility RCT was conducted in 19 adults (89.5% female, aged 20-69 years) with IBD and mild-moderate distress. Participants allocated to the WriteForIBD group completed a 4-day 30-min writing program adapted for IBD. The active control group wrote about trivial topics provided by researchers. Feasibility was established based on the recruitment and retention while acceptability based on completion rates and a numeric rating scale. All participants completed measures of mental health and disease activity before and after the intervention (one week) and at follow-up three months after the study commencement. The retention rate in the study was high (100% WriteForIBD; 82% control). All participants attended every session. 84.2% of participants were satisfied with the intervention. All participants reported a significant improvement in IBD-Control immediately after the intervention; F (2, 33.7) = 7.641, p = .002. A significant interaction of group*time for resilience was noted, R Online expressive writing is potentially feasible and highly acceptable to people with IBD who report distress. Future large-scale trials should explore the intervention that is adapted from this feasibility study. ID: ACTRN12620000448943p.
Sections du résumé
BACKGROUND
BACKGROUND
We explored feasibility, acceptability and preliminary efficacy of an online writing intervention (WriteforIBD) against an active control condition for distress in people with inflammatory bowel disease (IBD) at the time of the COVID-19 pandemic.
METHODS
METHODS
A feasibility RCT was conducted in 19 adults (89.5% female, aged 20-69 years) with IBD and mild-moderate distress. Participants allocated to the WriteForIBD group completed a 4-day 30-min writing program adapted for IBD. The active control group wrote about trivial topics provided by researchers. Feasibility was established based on the recruitment and retention while acceptability based on completion rates and a numeric rating scale. All participants completed measures of mental health and disease activity before and after the intervention (one week) and at follow-up three months after the study commencement.
RESULTS
RESULTS
The retention rate in the study was high (100% WriteForIBD; 82% control). All participants attended every session. 84.2% of participants were satisfied with the intervention. All participants reported a significant improvement in IBD-Control immediately after the intervention; F (2, 33.7) = 7.641, p = .002. A significant interaction of group*time for resilience was noted, R
CONCLUSIONS
CONCLUSIONS
Online expressive writing is potentially feasible and highly acceptable to people with IBD who report distress. Future large-scale trials should explore the intervention that is adapted from this feasibility study.
REGISTRATION
BACKGROUND
ID: ACTRN12620000448943p.
Identifiants
pubmed: 35716442
pii: S1744-3881(22)00084-6
doi: 10.1016/j.ctcp.2022.101616
pii:
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Pagination
101616Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.